BNN — BRAIN Biotech AG Cashflow Statement
0.000.00%
Last trade - 00:00- €51.12m
- €101.93m
- €55.50m
Annual cashflow statement for BRAIN Biotech AG, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.02 | -4.68 | -6.34 | -8.11 | -11.1 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -0.998 | -4.82 | -3.07 | -1.35 | -2.76 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.29 | 1.34 | 3.64 | 0.139 | 5.44 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.77 | -3.91 | -1.49 | -4.22 | -3.58 |
| Capital Expenditures | -2.86 | -1.26 | -6.08 | -2.64 | -1.73 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1.61 | -0.918 | -6.6 | 3.2 | 0.04 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.47 | -2.18 | -12.7 | 0.562 | -1.69 |
| Financing Cash Flow Items | 14.6 | 14.4 | 0 | -9.59 | 0.6 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 13.1 | 11.6 | -1.97 | 0.459 | 27 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.78 | 5.6 | -16.1 | -3.09 | 21.8 |